CEO: Thomas P. Dooley, PhD Dr. Dooley’s training included a BS in Cell Biology from the University of Kansas, a PhD in Molecular, Cellular & Developmental Biology from Indiana University, and a Helen Hay Whitney Postdoctoral Fellow at the Imperial Cancer Research Fund in London. He is an entrepreneur and inventor with three decades of R&D experience, including 18 years of leadership at the VP to CEO level in entrepreneurial companies. Previous employers included The Upjohn Co. (currently Pfizer), Southern Research, IntegriDerm, MediQuest Therapeutics, Agenta Biotechnologies, among others. Dr. Dooley is the recipient of 14 issued patents and numerous professional awards, including a prestigious endowed chair position. He is the author of 72 scientific articles, 3 books, and is the inventor of the PanX drugs.
ADVISORY BOARD: Charles B, Nemeroff, MD, PhD -- Chairman of Psychiatry and Behavioral Sciences, University of Miami T. Forcht Dagi, MD, MBA, DMedSc -- neurosurgeon and venture capitalist Howard Maibach, MD -- dermatologist and professor, University of California at San Francisco Charles Engles, PhD -- biomedical CEO Joel Dobbs, PharmD -- pharma CIO Doug Sanders, MBA -- pharma CFO Bill Garner, MD -- pharma CEO Royce Watkins, BS -- pharma CEO Doug Paul, PharmD, PhD -- pharma market research expert Doug Nesbitt, BS -- biomedical sales and marketing